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 WHAT IS THE ISSUE? 
There is a revived focus on breastfeeding and its benefits, especially 
because of the lack of significant progress in global rates of 
breastfeeding since the launch of the Innocenti Declaration in 1990 and 
the Baby Friendly Hospital Initiative in 1991 (Rollins et al. 2016). Women 
in high-income countries tend to breastfeed for shorter durations than 
those in low- and middle-income countries. Furthermore, even in low- and 
middle-income countries, less than two-fifths of infants under six months 
of age are breastfed exclusively, with a trend toward reductions in 
continued breastfeeding among poorer women (Victora et al. 2016). 
 
There is ample evidence for the potential of breastfeeding to further 
lower infant and child mortality and morbidity while simultaneously 
improving women’s health. Breastfed children tend to be protected from 
infections, have fewer dental malocclusions, and have higher intelligence 
than those who are not breastfed (Victora et al. 2016). It is estimated 
that improved breastfeeding practices could reduce more than 800,000 
deaths among children under age five and 20,000 deaths among women 
with breast cancer annually (Victora et al. 2016). Thus breastfeeding is a 
health behavior that impacts both mother and child and has the potential 
to contribute to the newly formulated Sustainable Development Goal 3, 
which focuses on good health and the well-being of individuals. It is 
within this context that a call for concerted action to protect, promote, 
and support breastfeeding has been issued (Rollins et al. 2016). 
 
Breastfeeding has also been identified as a high-impact intervention to 
achieve the Global Strategy for Women’s, Children’s and Adolescents’ 
Health (2016–2030), which was launched alongside the Sustainable 
Development Goals as a roadmap for ending preventable deaths in a 
generation. Breastfeeding is important to child survival in all settings and 
helps ensure that children can thrive and reach their full cognitive and 














   
 
PROGESTERONE VAGINAL RING 
BENEFICIAL ROLE IN SUPPORTING 
BREASTFEEDING 
Source: UN Photo/Albert González Farran 
https://mombloggersforsocialgood.com/2012/12/05/ 
exclusive-breastfeeding-increases-in-kenya/ 
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BENEFITS OF BREASTFEEDING 
Breastfeeding is a low-cost and readily available 
intervention with enormous benefits for both mother and 
baby. Breast milk provides infants with all the nutrients 
they need for healthy development as well as protection 
against diarrhea and pneumonia, the two primary causes 
of child mortality worldwide (Horta and Victora 2013).  
Evidence also suggests that breastfeeding contributes to 
improved outcomes in later life; adolescents and adults 
who were breastfed as babies are less likely to be 
overweight/obese or have type 2 diabetes, and perform 
better in intelligence tests.   
Mothers also receive both short- and long-term benefits. In 
the short term, exclusive breastfeeding can protect 
against pregnancy (98% protection in the first six months 
after birth) and postpartum depression, and in the longer 
term can reduce risks of breast and ovarian cancers, as 










   
 
 
 PROGESTERONE VAGINAL RING  
The Progesterone Vaginal Ring (PVR) is a new 
contraceptive designed for use by breastfeeding women to 
extend the period of lactational amenorrhea and promote 
birth spacing (RamaRao et al. 2013). The natural 
progesterone contained in the ring does not interfere with 
breastfeeding, and the progesterone is inactivated quickly 
when ingested orally; the infant is not exposed to the 
hormone if a small amount is secreted into breast milk 
(Massai et al. 1999; Massai et al. 2000).   
 
The effectiveness of the PVR depends on the user 
breastfeeding her child at least four times a day, with 
fewer feeds reducing effectiveness. Hence, in populations 
where breastfeeding is an accepted behavior but with 
potential for reductions in how often it is practiced, the 
PVR provides an additional rationale to promote and 
support sustained or increased nursing. The PVR is 
included in the Fifth Edition of the WHO Medical Criteria 
for Contraceptive Use (WHO 2015). 
 
The PVR is an ideal tool to achieve two different but 
connected health outcomes. On the one hand, it supports 
(and even promotes) breastfeeding so that infants and 
children are well nourished, protected from a host of 
illnesses, and benefit from nursing that is uninterrupted by 
a pregnancy. On the other hand, the PVR enhances 
contraceptive protection for the mother so that she has 
ample time to recover from the previous pregnancy and 






The PVR is composed of silicone 
elastomer with progesterone dispersed 
throughout the ring matrix. Each ring 
delivers a daily dose of 10 mg of 
progesterone and can be used 
continuously for up to 3 months. A user 
can use 4 rings consecutively for 12 
months of contraceptive protection. 
Women can begin to use the PVR at 4 
weeks postpartum. 









LINKS BETWEEN BREASTFEEDING, 
NUTRITION, AND POSTPARTUM 
CONTRACEPTION  
DHS data reveal that malnutrition is a global concern 
that requires immediate attention, especially in sub-
Saharan Africa and South Asia. Malnutrition arises 
when an individual lacks macronutrients, such as 
carbohydrates and proteins, or micronutrients (vitamins 
and minerals), or both. Infants and children under the 
age of five years are especially susceptible to 
malnutrition, leading to stunting, wasting, and 
underweight conditions. Addressing malnutrition is 
essential for reducing childhood mortality and 
morbidity.  
 
Nutrition from breast milk, especially during the first two 
years of a child’s life, is a naturally potent means of 
combating the various outcomes of malnutrition and of 
increasing immediate and long-term immunity. 
Exclusive breastfeeding during the first four months is 
especially crucial to provide nutrients to the infant that 
other supplements are unable to adequately provide in 
order to protect the child from infections, anemia, and 
other outcomes of malnutrition, while bonding the 
mother and child (World Food Programme 2005). In 41 
states throughout sub-Saharan Africa and India, 
exclusive breastfeeding ranges between 96% and 98% 
for the first two to four months of an infant’s life. 
Further, continued breastfeeding in addition to 
supplemental food and milk continue between 18 and 
25 months according to DHS data. Continued 
breastfeeding also provides benefits for the mother, 
specifically by reducing stress, increasing bonding with 
the child, and providing a constant source of nutrition in 
emergency situations (UNICEF). A malnourished woman 
may still breastfeed and provide the necessary nutrients 
to her child, although additional support from food and 
supplements would increase her ability to lactate 
(UNICEF).  
 
Since breastfeeding is vital for the health of both the 
mother and baby through increased bonding and 
continued nutrition, preventing pregnancy in the first 
year postpartum is important. Less than 1% of women 
currently use LAM, with no more than 6% having ever 
used the method in select countries. Given the 
frequency with which women have to breastfeed 
exclusively immediately after giving birth for up to six 
months, after which LAM no longer guarantees 
contraceptive protection, the need for contraceptive use 
is high.  
 
BENEFITS OF USING 
CONTRACEPTION 
WHO recommends an interval of 24 months or more 
after a live birth before becoming pregnant, in order to 
reduce poor health outcomes for mother and baby 
(WHO 2007). However, considerable proportions of 
pregnancies occur within 24 months of a live birth; data 
from 22 Demographic and Health Surveys (DHS) 
indicate that over 50% of non-first pregnancies 
occurred within 24 months of the previous birth (Moore 
et al. 2015). Given the potential for postpartum family 
planning to meet women’s contraceptive needs and 
contribute to healthier babies and mothers, WHO and 
its partners have issued new guidance for postpartum 
family planning (WHO 2013). The guidance covers 
important topics such as: raising awareness of family 
planning needs among postpartum women, reducing 
missed opportunities across the continuum of care, 
organizing health services to include contraceptive 
counseling, maximizing the availability of community-
based care, and expanding the range of family planning 
options and services.  
 
The lactational amenorrhea method, or LAM, is 
recommended for up to six months postpartum for 
women who do not wish to use modern contraception. 
LAM is effective under three conditions. First, LAM 
requires that the new mother exclusively breastfeed 
every four hours during the day and every six hours at 
night and desist from feeding water, formula, or other 
milk. Second, the method works for up to the first six 
months postpartum, after which the new mother will 
have to utilize other methods to prevent pregnancy. 
Third, LAM is only effective provided the woman has not 
started menstruating since giving birth. These stringent 
conditions limit the proportion of women who are able 
to use LAM effectively (Sitruk-Ware et al. 2016). The 
PVR is an option for those women who wish to 
breastfeed but are not able to use LAM and are seeking 
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1 Average of 40 countries listed in the Appendix from DHS data. 
 
 
CALL TO ACTION: ROLE OF 
STAKEHOLDERS  
Breastfeeding is a right to health for women and 
their children and concerted action by public and 
private actors is critical. Women need support to 
initiate and continue breastfeeding their babies. 
Currently, women do not breastfeed for a 
multitude of reasons ranging from lack of 
knowledge about the latest scientific evidence, 
work pressures, inconvenience, limited provider 
guidance, and lack of familial or community 
support. Successful breastfeeding requires 
protection and support from multiple actors in the 
health arena, and the following lays out actions 
that they can take:   
 
Policy and program managers can emphasize the 
importance of breastfeeding as a key public health 
approach that can prevent multiple diseases and 
improve the health of mothers and babies 
(McFadden et al. 2016).   
 Decision-makers can situate breastfeeding 
within larger health and developmental 
agendas. 
 Decision-makers can ensure that 
breastfeeding is better integrated across 
service programs, in particular family 
planning, so that breastfeeding is not isolated 
within infant and child feeding and nutrition 
programs.   
 A well-integrated breastfeeding program will 
incorporate the array of tools and technologies 
that are available to support and promote 
breastfeeding; key examples include LAM and 
the PVR.   
 
Health regulators can monitor and stop false 
advertising from companies that promote breast-
milk substitutes as being superior to breast milk.   
 Regulators should monitor and implement 
existing laws that penalize breast-milk 
substitute companies for false or deceptive 
advertising thereby signaling explicit support 
for breastfeeding initiatives. 
 Regulators can introduce appropriate and 
good-quality technologies that promote and 
support breastfeeding, such as breast pumps, 
relevant medications that increase the 
production of breast milk, and contraceptives 
such as the Progesterone Vaginal Ring 
developed for nursing women. 









Providers can support breastfeeding women at the 
various points of service contact they have with women 
and their babies, whether at health facilities or through 
community outreach.   
 Providers, irrespective of their training and 
professional responsibilities, should support and 
promote breastfeeding. For example, obstetricians 
and gynecologists should counsel women during 
antenatal and postnatal visits regarding the 
benefits of breastfeeding. Frontline workers such as 
nurses, midwives, and community-based health 
workers should teach and support women on the 
art of optimal breastfeeding. 
 Providers can counsel a breastfeeding woman 
about contraceptive options such as LAM, the PVR, 
and other progestin-based methods should she 
desire to avoid or delay the next pregnancy. 
 
Health advocates can argue for regulations and 
guidelines that expand maternity benefits, including 
those at the workplace.   
 Advocates can fight for private places for women to 
breastfeed or express milk in both public and 
private spaces and thereby support women’s 
decisions to nurse their babies.  
 Advocates can create the agenda that supports 
workplace entitlements that provide women with 
the time (maternity leave), space (nursing rooms), 
and flexibility to manage work and childrearing 
responsibilities. 
 Advocates can disseminate key messages on 
breastfeeding and family planning that support the 
health of mothers and babies. They can partner 
with technical-support agencies in distilling and 
translating science-based messages for actions. 
 
Families and community members at large can play an 
influential role in supporting a woman’s decision and 
right to breastfeed (Lawn and Kerber 2006).  
 Family members including spouses can support a 
woman’s decision to nurse and to use 
contraception. They can provide her relief from 
household chores, give her time and space to 
nurse, and offer practical advice and support. 
 Communities can allocate a positive value to 
breastfeeding and address any stigma—such as not 
being a modern behavior—that is attached to 
breastfeeding.   
 Communities can create mother-to-mother support 
groups, breastfeeding support groups, or mothers’ 
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Outcomes of Malnourishment 
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44.6 16 21.3 89.8 3.3 19.4 0.4 3.9 43.1 
Botswana 1988 DHS 34.6 15.5 25.7 96 2.7 17.8 0.1 1.1 43.2 
Burkina Faso 2010 DHS 57.7 5.8 28.8 99.1 2.2 23.9 0 6.9 45.9 
Burundi 2010 DHS 32.5 5.6 14.6 98.7 4.8 25 0.2 6.9 40.9 






44.6 15.9 32.6 99.8 0.9 21.2 0.5 14.6 48.8 
Chad 1996-97 
DHS 
30.1 11.1 15.3 99.5 0.8 21.7 0.4 0.4 44.9 











29.8 7.5 14.9 98.4 3.6 21.8 0 3.3 41.1 
Cote d'Ivoire 2011-12 
DHS 
42.9 14.9 33.8 96.4 1.4 18.9 0.1 9 38 
Eritrea 2002 DHS 44.4 9.7 28.7 100 4.3 22.3 1.1 5.1 49.7 
Ethiopia 2011 DHS 16.5 3.3 6 98.5 4.2 25.3 0.1 2.7 49 
Gabon 2012 DHS 24.5 11.5 16.2 88 1.1 11.6 0.1 23.9 28.8 
Gambia 2013 DHS 18.8 4.7 11 99.2 3.6 20.7 0 5 45.6 
Ghana 2014 DHS 31.2 9.6 18 99.2 3.9 21.2 0.8 3.6 36.2 
Guinea 2012 DHS 26 4 11 98.2 2.2 22.8 0.3 8.3 63.2 
Kenya 2014 DHS 33.2 2.8 10.3 99.5 4.3 21.3 0 1.9 31.3 
Lesotho 2014 DHS 31.6 6 15 93.6 4.5 16.6 0.1 3.1 40.4 
Liberia 2013 DHS 50.1 
  
98.4 4 19.6 0.1 17.1 40.4 
Madagascar 2008-09 
DHS 
47.1 4 12.8 99.6 3.7 22.5 3.5 1.7 34.2 
Malawi 2010 DHS 38.3 12.7 25.5 99.4 4.7 23 0.3 0.3 39.8 
Mali 2012-13 
DHS 
38.9 14.5 27.8 95.7 3.3 22.6 0.1 16 40.4 
Mauritania 2000-01 
DHS 
42.6 5.9 14.9 98.8 2.2 19.7 0.4 3.8 37.3 
Mozambique 2011 DHS 23.7 6.2 13.3 97.5 3.5 20.4 0.1 
 
49.5 
Namibia 2013 DHS 43.9 18 36.4 92 3.5 14.8 0.7 
 
41.7 
Niger 2012 DHS 36.8 18 28.7 98.2 2.1 20.4 0.8 
 
42.6 












18.7 5.9 12.6 100 4 18 0.5 
 
32 
Senegal 2014 DHS 37.9 9.3 16.4 99.1 2.7 20.3 0.1 
 
36.7 
Sierra Leone 2013 DHS 28.9 2.5 5.4 96.4 2.9 19 
  
52.7 










33.4 4.7 13.8 89.9 2.6 15.6 
  
42.4 





32.0 3.0 9.7 98.4 4 22.5 
  
39.1 
Uganda 2011 DHS 
   





   





   
96.7 2.8 17.5 
  
40.2 
